Categories:

cGMP requirements for Latin American drug products MA submissions – updated 18th May 2021

A marketing authorization submission represents a major effort for the pharmaceutical industry, and

Ler mais

Latin America – Regulatory Agencies

Latin America is increasingly raising interest from pharmaceutical companies in other regions. It is

Ler mais

New Brazilian Regulatory Framework for API under Public Consultation

Approved by Anvisa’s Board of Directors, the Public Consultations of the New Regulatory Framew

Ler mais

EDQM- Published updated list of drafts of monographs for the European Pharmacopoeia

EDQM has published a statement with the updated list of substances which the drafts of its monograph

Ler mais